Literature DB >> 27325943

Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy.

Takashi Iwase1, Shoichiro Takao2, Masashi Akaike1, Katsuhito Adachi3, Yuka Sumitomo-Ueda4, Shusuke Yagi1, Toshiyuki Niki1, Kenya Kusunose1, Noriko Tomita1, Yoichiro Hirata1, Koji Yamaguchi1, Kunihiko Koshiba1, Yoshio Taketani1, Hirotsugu Yamada1, Takeshi Soeki1, Tetsuzo Wakatsuki1, Ken-Ichi Aihara4, Masafumi Harada2, Hiromu Nishitani5, Masataka Sata1.   

Abstract

BACKGROUND: Cardiac involvement is a recognised complication in female carriers of Duchenne muscular dystrophy (DMD). Since segmental or global left ventricle (LV) wall motion abnormalities in DMD carriers can arise even without apparent muscle weakness, it is difficult to differentiate cardiac involvement of a DMD carrier from other heart diseases in a non-invasive manner. Cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) enables assessment of regional wall motion abnormality and myocardial damage with high spatial resolution.
OBJECTIVE: To assess the utility of CMR for detection of myocardial damage in female carriers of DMD. METHODS AND
RESULTS: Gadolinium-enhanced CMR was performed in seven female DMD carriers. Physical examination, electrocardiography, chest radiograph, measurements of total creatinine kinase and brain natriuretic peptide levels, and two-dimensional echocardiography were also performed. Four (57%) of the seven carriers had LGE, and LGE was frequently observed at the subepicardial layer in the inferolateral segment. Two carriers had a focal LGE at the LV inferolateral wall without LV dilation or wall motion abnormalities.
CONCLUSION: CMR findings of DMD carriers were characterised by subepicardial LGE, which was localised at inferolateral segments. CMR may be a useful modality for detecting cardiac involvement in DMD carriers.

Entities:  

Keywords:  MRI; cardiomyopathies; gadolinium; muscular dystrophies

Year:  2010        PMID: 27325943      PMCID: PMC4898527          DOI: 10.1136/ha.2010.002006

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  21 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.

Authors:  K Bushby; F Muntoni; J P Bourke
Journal:  Neuromuscul Disord       Date:  2003-02       Impact factor: 4.296

3.  Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.

Authors: 
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

4.  Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.

Authors:  L Grain; M Cortina-Borja; C Forfar; D Hilton-Jones; J Hopkin; M Burch
Journal:  Neuromuscul Disord       Date:  2001-03       Impact factor: 4.296

5.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

6.  Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy.

Authors:  E M Hoogerwaard; P A van der Wouw; A A Wilde; E Bakker; P F Ippel; J C Oosterwijk; D F Majoor-Krakauer; A J van Essen; N J Leschot; M de Visser
Journal:  Neuromuscul Disord       Date:  1999-07       Impact factor: 4.296

7.  Plasma levels of brain natriuretic peptide as an index for evaluation of cardiac function in female gene carriers of Duchenne muscular dystrophy.

Authors:  K Adachi; H Kawai; M Saito; T Naruo; C Kimura; H Mine; T Inui; S Kashiwagi; M Akaike
Journal:  Intern Med       Date:  1997-07       Impact factor: 1.271

Review 8.  The muscular dystrophies.

Authors:  Alan E H Emery
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

9.  Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  J A McCrohon; J C C Moon; S K Prasad; W J McKenna; C H Lorenz; A J S Coats; D J Pennell
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

10.  Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.

Authors:  Bernhard L Gerber; Jérôme Garot; David A Bluemke; Kathérine C Wu; João A C Lima
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

View more
  1 in total

1.  Muscular and cardiac manifestations in a Duchenne-carrier harboring a dystrophin deletion of exons 12-29.

Authors:  Josef Finsterer; Claudia Stöllberger; Birgit Freudenthaler; Desiree De Simoni; Romana Höftberger; Klaus Wagner
Journal:  Intractable Rare Dis Res       Date:  2018-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.